Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413595
Status:
COMPLETED
Last Update Posted:
2021-04-12
First Post:
2006-12-19
Brief Title:
Stroke in Young Fabry Patients sifap2 Characterization of the Stroke Rehabilitation
Sponsor:
Organization:
CENTOGENE GmbH Rostock
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
EDTA-blood and urine sample for central laboratory analysis of agalsidase antibodies and Gb3 for safety issues
There will be a proteomic analysis in blood to check whether there will be the possibility to characterize a biomarker for Fabry disease
Enrollment Count:
100
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 2757 |
Who Masked List: